INS and Hyperglycemia: The association between suppressed ILDR2 expression in β-cells and decreased insulin secretion may be an important component of a new pathway in hypoinsulinemic hyperglycemia, and thus may be a target for diabetic therapeutic modulation for decreased insulin secretion.